Workflow
上市公司信息披露违规
icon
Search documents
万马股份(002276.SZ)收到浙江证监局警示函
智通财经网· 2025-08-17 16:10
浙江证监局在现场检查中发现公司部分投资事项未及时经董事会审议并对外披露,部分投资项目重大进 展情况未披露或未及时披露。 公司上述相关行为违反了《上市公司信息披露管理办法》(证监会令第182号)第三条第一款规定,公司 时任董事长李刚、总经理徐兰芝、时任总经理张珊珊、董事会秘书赵宇恺违反了《上市公司信息披露管 理办法》(证监会令第182号)第四条,第五十一条第一款、第二款规定。根据《上市公司信息披露管理 办法》(证监会令第182号)第五十二条规定,浙江证监局决定对公司、李刚、徐兰芝、张珊珊、赵宇恺 分别采取出具警示函的监督管理措施,并记入证券期货市场诚信档案。 万马股份(002276.SZ)发布公告,近日,公司及相关人员收到中国证券监督管理委员会浙江监管局(简 称"浙江证监局")出具的《关于对浙江万马股份有限公司及相关人员采取出具警示函措施的决定》 (〔2025〕177号)(简称《警示函》)。 登录新浪财经APP 搜索【信披】查看更多考评等级 ...
ST柯利达: 柯利达装饰股份有限公司关于公司及相关人员收到江苏证监局警示函的公告
Zheng Quan Zhi Xing· 2025-08-08 13:08
Group 1 - The company received a warning letter from the Jiangsu Securities Regulatory Bureau regarding financial accounting and disclosure issues related to accounts receivable and contract assets [2][3] - The warning letter highlighted that the company failed to adequately assess the impairment of accounts receivable and contract assets, violating relevant accounting standards [2] - The chairman and the financial director of the company were held primarily responsible for the violations and were instructed to enhance their understanding of securities laws and regulations [2][3] Group 2 - The company emphasized its commitment to addressing the issues raised in the warning letter and improving compliance with relevant regulations [3] - The regulatory measures imposed will not affect the company's normal production and operational activities [3] - The company will continue to fulfill its information disclosure obligations in a timely manner as per regulatory requirements [3]
两名董事弃权!精艺股份原董事长“老赖”身份曝光次日辞职,“80后”财务总监将接棒
Mei Ri Jing Ji Xin Wen· 2025-07-15 13:44
Core Points - The former chairman of Jingyi Co., Ltd. resigned due to exposure of a dishonesty record, leading to the election of a new chairman, Gu Chong, who is a financial director born in the 1980s [1][5][6] - Gu Chong has a background in finance, having previously worked at Nantong Sanjian Group and its holding company, which is also a major shareholder of Jingyi [3][4] - Following the leadership change, Jingyi's stock price experienced significant volatility, reaching a recent high before a sharp decline on the day of the new chairman's election [4][6] Company Background - Jingyi Co., Ltd. was established in 1999 and listed on the Shenzhen Stock Exchange in 2009, primarily engaged in copper processing products [4] - The company has faced substantial revenue fluctuations over the past five years, with a reported revenue drop of over 60% in 2022 and net profit consistently below 100 million yuan [4] Regulatory Context - The resignation of the former chairman was prompted by a regulatory decision from the Guangdong Securities Regulatory Commission, which highlighted failures in disclosing the chairman's dishonesty status [5][6] - The commission mandated Jingyi to rectify its governance issues and replace the chairman within two trading days of the decision [5]
*ST观典: 关于公司及相关人员收到北京证监局行政监管措施决定书的公告
Zheng Quan Zhi Xing· 2025-07-07 15:11
Core Viewpoint - The company, Guandian Defense Technology Co., Ltd., has been penalized by the Beijing Securities Regulatory Bureau for violations related to fund occupation and inadequate disclosure of financial information [1][2][3]. Summary by Sections Regulatory Decision - The company was found to have occupied non-operating funds amounting to 142.5147 million yuan, with an outstanding balance of 96.9472 million yuan as of April 2025 [1]. - The actual controller, Gao Ming, admitted to the fund occupation and was involved in falsifying bank documents [1][2]. Violations and Responsibilities - The company's actions violated the "Management Measures for Information Disclosure of Listed Companies" and relevant regulatory guidelines [2]. - Key individuals, including Gao Ming and other executives, are held responsible for the violations [2]. Required Actions and Compliance - The company is mandated to take corrective actions and submit a written report to the regulatory authority within 15 working days [3]. - The company must enhance its internal controls and improve the quality of information disclosure to prevent future occurrences [3][4]. Company Response - The company has acknowledged the issues raised in the regulatory decision and is committed to strengthening compliance with relevant laws and regulations [4]. - The company assures that the regulatory decision will not impact its normal operations and will continue to fulfill its disclosure obligations [4].
佛山一上市公司董事长辞职
Sou Hu Cai Jing· 2025-06-27 10:35
Core Viewpoint - The chairman of Jingyi Co., Ltd., Huang Yuhui, has resigned from his positions due to being listed as a dishonest executor, which disqualifies him from holding office according to regulatory standards [1][3][4]. Group 1: Company Governance - Huang Yuhui applied to resign from his roles as chairman, director, and committee member of Jingyi Co., Ltd. following a directive from the Guangdong Securities Regulatory Bureau [1][3]. - The Guangdong Securities Regulatory Bureau found that Jingyi Co., Ltd. failed to disclose Huang Yuhui's status as a dishonest executor, violating multiple disclosure regulations [3][4]. - The company is required to replace its chairman and disclose relevant information within two trading days, as mandated by the regulatory authority [4]. Group 2: Company Background - Jingyi Co., Ltd. was established in 1999 and is a leading enterprise in copper processing and trading in South China, with 23 subsidiaries in various sectors including new energy and photovoltaics [1]. - The company has been closely linked to the industrial upgrading of its local area in Foshan, where it has operated for 26 years [1]. Group 3: Legal and Regulatory Issues - Huang Yuhui's inclusion in the dishonest executor list constitutes a violation of the Company Law, which prohibits individuals in such a status from serving as directors or senior management [4]. - The regulatory body has issued a warning to Huang Yuhui and other key executives for their failure to fulfill their disclosure obligations [4].
江苏证监局关于对博瑞生物医药(苏州)股份有限公司、邹元来采取出具警示函措施的决定
Xin Lang Cai Jing· 2025-06-27 08:22
Group 1 - The company, Borui Biopharmaceutical (Suzhou) Co., Ltd., approved a proposal to use up to RMB 380 million of temporarily idle raised funds for cash management, with a usage period not exceeding 12 months from the date of board approval [1] - The company failed to redeem the cash management products in a timely manner by the deadline of November 26, 2020, and did not hold a board meeting to review the cash management situation until December 11, 2020, violating disclosure obligations [1] - The actions of the company were found to be in violation of the relevant regulations regarding information disclosure and management of raised funds [1] Group 2 - The financial director, Zou Yuanlai, did not fulfill his responsibilities in ensuring the proper use of raised funds and timely disclosure of related information, which also constituted a violation of regulations [2] - The Jiangsu Securities Regulatory Bureau decided to issue a warning letter as an administrative regulatory measure and record it in the securities and futures market integrity file [2] - The company is required to enhance compliance awareness and submit a written report to the regulatory bureau within 10 working days of receiving the decision [2]
精艺股份: 关于收到广东证监局对公司采取责令改正措施并对黄裕辉等采取出具警示函措施的决定的公告
Zheng Quan Zhi Xing· 2025-06-24 19:18
Group 1 - The Guangdong Securities Regulatory Commission has issued a decision to Guangdong Precision Metal Co., Ltd. (referred to as "the company") to take corrective measures and issue warning letters to its chairman Huang Yuhui and others due to violations of disclosure regulations [1][2] - The company failed to disclose the actual controller and chairman Huang Yuhui's status as a dishonest executor, which is a violation of the Information Disclosure Management Measures for Listed Companies [1][2] - Huang Yuhui, the current chairman, is listed as a dishonest executor by the court, which disqualifies him from holding the position under the Company Law [2] Group 2 - The company and its executives, including chairman Huang Yuhui, general manager Wei Guo, and board secretary Yang Xiangrui, are held primarily responsible for the violations and have been ordered to take corrective actions within two trading days [3] - The company must replace its chairman and accurately disclose relevant information, submitting a rectification report to the regulatory authority within 30 days [3] - The regulatory measures can be contested through administrative review or litigation within specified timeframes, but the enforcement of these measures will not be suspended during the review or litigation period [3]
*ST恒立: 关于收到行政处罚事先告知书的公告
Zheng Quan Zhi Xing· 2025-06-18 10:57
Group 1 - The core issue is that Hengli Industrial Development Group Co., Ltd. is facing administrative penalties for failing to disclose its 2024 annual report on time, which has led to a warning of potential delisting from the Shenzhen Stock Exchange [2][4][7] - The company reported an adjusted revenue of 196 million yuan for 2024, which is below the 300 million yuan threshold required to avoid delisting [3][4] - The company has been under investigation by the China Securities Regulatory Commission (CSRC) for this failure, and a notice of administrative penalty has been issued [2][7] Group 2 - The CSRC has proposed a fine of 3.5 million yuan for the company and additional fines for key executives, including 1.8 million yuan for the chairman and 1.6 million yuan for the president and CFO [7][8] - The company’s chairman, Stone Shengping, failed to ensure the timely preparation of financial reports, which contributed to the non-disclosure of the annual report [4][5][7] - Other executives and independent directors also failed to fulfill their responsibilities in overseeing the financial reporting process, leading to the company's current predicament [5][6][7]
ST逸飞: 逸飞激光关于收到湖北证监局警示函的公告
Zheng Quan Zhi Xing· 2025-05-30 10:41
Core Viewpoint - Wuhan Yifei Laser Co., Ltd. received a warning letter from the Hubei Securities Regulatory Bureau due to significant discrepancies in its financial disclosures, particularly in its annual report and performance announcement [1][2]. Group 1: Violation Details - The company reported a net profit attributable to shareholders of 24.32 million yuan, a decrease compared to the previous year's net profit of 45.315 million yuan [1]. - The company corrected its 2024 annual report, revealing an operating income of 692.0687 million yuan, a net profit of 24.32 million yuan, and a net profit of 9.4123 million yuan after deducting non-recurring gains and losses [1]. Group 2: Regulatory Actions - The company's actions violated the "Administrative Measures for Information Disclosure of Listed Companies," specifically Articles 3 and 17 [2]. - Key executives, including the chairman and general manager, the financial director, and the board secretary, were held primarily responsible for the violations [2]. - The Hubei Securities Regulatory Bureau decided to issue a warning letter and record it in the securities and futures market integrity file [2]. Group 3: Company Response - The company and responsible personnel acknowledged the warning and committed to learning from the issues raised, enhancing compliance with relevant laws and regulations, and improving the quality of information disclosure [2].
青海春天药用资源科技股份有限公司关于收到中国证券监督管理委员会青海监管局警示函的公告
Core Viewpoint - Qinghai Spring Pharmaceutical Resources Technology Co., Ltd. received a warning letter from the China Securities Regulatory Commission (CSRC) for failing to disclose related party transactions and relationships with Yibin Tinghua Wine Industry Development Co., Ltd. [1][2] Group 1: Regulatory Actions - The CSRC's Qinghai Regulatory Bureau issued a decision to order Qinghai Spring to rectify its actions and warned key individuals including Chairman Zhang Xuefeng and others for their responsibilities in the violations [2][3] - The company is required to correct the violations within 30 days and submit a written rectification report [3] Group 2: Violations and Responsibilities - Qinghai Spring violated multiple provisions of the Information Disclosure Management Measures, including failing to disclose related party relationships and transaction procedures [2] - Key individuals, including the chairman and financial director, are held primarily responsible for these violations [2]